META vs MTCH
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
META exhibits exceptional fundamental health with a Piotroski F-Score of 8/9, indicating strong financial strength across profitability, leverage, and operating efficiency. While the current price of $612.42 trades at a premium to the Graham Number ($213.17) and the growth-based Intrinsic Value ($542.14), the PEG ratio of 0.94 suggests the stock is undervalued relative to its high growth rate. Strong revenue growth (23.8%) and a low forward P/E (17.03) outweigh the bearish technical trend and insider selling. The company's dominant market position and consistent earnings beats support a bullish long-term outlook.
MTCH presents as a deep-value opportunity with a Piotroski F-Score of 4/9, indicating stable financial health. While the 5-year price performance is disastrous (-76.2%), the current valuation is highly attractive with a PEG ratio of 0.30 and a current price ($33.59) trading at a significant discount to its growth-based intrinsic value of $70.21. Strong operating margins (30.02%) and robust earnings growth (40.60%) are offsetting stagnant revenue growth. The stock is fundamentally undervalued, though it faces headwinds from bearish technical trends and insider selling.
Compare Another Pair
Related Comparisons
META vs MTCH: Head-to-Head Comparison
This page compares Meta Platforms, Inc. (META) and Match Group, Inc. (MTCH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.